KCNF1 Gene

📖 Wiki Page

gene1063 wordssynced 2026-04-02

KCNF1 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">KCNF1 Gene</th>
</tr>
<tr>
<td class="label">Gene symbol</td>
<td>KCNF1</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Kv5.1 modulatory subunit</td>
</tr>
<tr>
<td class="label">Gene ID</td>
<td>3777</td>
</tr>
<tr>
<td class="label">Canonical UniProt entry</td>
<td>Q9H5Y4</td>
</tr>
<tr>
<td class="label">Functional class</td>
<td>Electrically silent Kv channel subunit</td>
</tr>
<tr>
<td class="label">Subunit</td>
<td>Type</td>
</tr>
<tr>
<td class="label">Kv1.x</td>
<td>Conducting</td>
</tr>
<tr>
<td class="label">Kv2.x</td>
<td>Conducting</td>
</tr>
<tr>
<td class="label">Kv5.1 (KCNF1)</td>
<td>Modulatory</td>
</tr>
<tr>
<td class="label">Kv6.x</td>
<td>Modulatory</td>
</tr>
<tr>
<td class="label">Kv9.x</td>
<td>Modulatory</td>
</tr>
<tr>
<td class="label">Compound Class</td>
<td>Target</td>
</tr>
<tr>
<td class="label">4-AP</td>
<td>Kv channels</td>
</tr>
<tr>
<td class="label">Retigabine</td>
<td>KCNQ (Kv7)</td>
</tr>
<tr>
<td class="label">DPP inhibitors</td>
<td>Kv11.1</td>
</tr>
<tr>
<td class="label">Kv5.1-selective</td>
<td>TBD</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

...

KCNF1 Gene

Overview

KCNF1 encodes Kv5.1, an electrically silent voltage-gated potassium channel subunit in the Kv channel family.[@bocksteins2012][@gutman2003] Silent Kv subunits typically do not form high-function homotetrameric channels on their own; instead, they heteromerize with conducting subunits (especially Kv2-family proteins) to reshape gating kinetics, voltage dependence, and channel trafficking.[@bocksteins2012][@pongs2010]

In neurodegeneration modeling, this makes KCNF1 a plausible network modulator rather than a primary disease gene. Changes in modulatory subunits can shift firing adaptation, burst propensity, and calcium entry burden, which are core determinants of vulnerability in disorders such as [Parkinson's disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), and [frontotemporal-dementia](/diseases/frontotemporal-dementia).[@styr2018][@roselli2009]

Gene And Protein Context

Kv5.1 sits within the broader potassium channel regulatory landscape controlling repolarization reserve and spike-frequency adaptation.[@gutman2003][@pongs2010] Because these features tune synaptic integration and metabolic demand, seemingly subtle channel-complex shifts can produce major systems-level effects over long disease timelines.[@styr2018][@roselli2009]

Mechanistic Role In Nervous-System Stress Biology

1. Repolarization And Firing Pattern Control

Kv channel complexes limit runaway depolarization and constrain repetitive firing. Modulatory subunits such as Kv5.1 can alter activation/inactivation profiles of channel assemblies and thereby influence excitability set points.[@bocksteins2012][@pongs2010] This matters in neurodegeneration where chronic hyperexcitability is linked to calcium overload and synaptic failure.[@styr2018]

2. Calcium Burden Coupling

Action-potential waveform and afterhyperpolarization shape calcium influx. Channel-complex remodeling that impairs repolarization can increase intracellular calcium load and activate downstream stress pathways, including mitochondrial dysfunction, proteostasis strain, and inflammatory signaling.[@styr2018][@roselli2009][@surmeier2017]

3. Circuit-Level Instability

Disease progression in AD/PD/ALS is increasingly viewed through network dysfunction, not only cell-autonomous pathology. Ion-channel modulators like KCNF1 are candidates for explaining why some circuits destabilize earlier under similar pathological protein burdens.[@styr2018][@roselli2009]

Human Evidence Status

Current direct human genetic evidence linking KCNF1 to common neurodegenerative syndromes remains limited. The stronger evidence base is mechanistic and comparative:

Kv family channel dysregulation is repeatedly observed in vulnerable neuronal populations.[@gutman2003][@styr2018]
Excitability signatures correlate with disease stage and progression in multiple disorders.[@styr2018][@roselli2009]
Modulatory subunit biology provides a tractable framework for interpreting these shifts.[@bocksteins2012][@pongs2010]

Accordingly, KCNF1 is best classified as an emerging systems-modifier candidate for disease stratification and hypothesis generation.

Translational Implications

Potential near-term applications include:

integrating KCNF1 expression with electrophysiology biomarkers to identify hyperexcitability-prone subgroups,

testing whether Kv-complex normalization synergizes with mitochondrial or anti-inflammatory interventions,

prioritizing KCNF1-containing channel complexes in human iPSC neuron perturbation studies.[@styr2018][@roselli2009][@surmeier2017]

Drug development targeting silent Kv subunits is still early-stage; most actionable work today is mechanistic mapping and patient stratification.

Research Priorities

Resolve Kv5.1-containing channel stoichiometry across disease-relevant neuronal subtypes.
Quantify whether KCNF1 variation changes progression slopes in longitudinal cohorts.
Test causal links between Kv5.1 perturbation, calcium dysregulation, and neuronal survival in human-derived models.

Kv Channel Family Context

The voltage-gated potassium channel family comprises multiple subfamilies:

KCNF1 exhibits the highest co-assembly with Kv2.1 (KCNB1), which is highly expressed in cortical and hippocampal pyramidal neurons. This makes the Kv2.1/Kv5.1 complex particularly relevant to understanding hippocampal dysfunction in [Alzheimer's disease](/diseases/alzheimers-disease)[@styr2018].

Structural Features

Transmembrane Architecture

Kv5.1 contains six transmembrane helices (S1-S6) typical of voltage-gated potassium channels:

S1-S4: Voltage-sensing domain (VSD)
S5-S6: Pore domain (PD)
N-terminal domain: Regulatory cytoplasmic region
C-terminal domain: Interaction surfaces for modulatory subunits

Unlike conducting Kv subunits, Kv5.1 lacks key residues in the pore region that would permit ion conduction. However, it retains a functional VSD capable of sensing membrane potential changes[@bocksteins2012].

Heteromer Assembly

Kv5.1 co-assembles with Kv2 family members through:

N-terminal interactions: T1 domain-mediated tetramerization

Transmembrane contacts: Interface between VSD and PD

C-terminal associations: PDZ-binding motifs

Disease-Specific Mechanisms

Alzheimer's Disease

In AD, Kv channel dysfunction contributes to:

Neuronal hyperexcitability: Early network hyperactivity observed in AD mouse models correlates with reduced Kv channel function[@styr2018]
Calcium dysregulation: Impaired repolarization prolongs action potentials, increasing calcium influx through voltage-gated channels
Synaptic failure: Homeostatic plasticity disruptions driven by firing rate instability[@styr2018]

Parkinson's Disease

Dopaminergic neurons in the substantia nigra pars compacta are particularly vulnerable:

Metabolic demand: Elevated firing rates require precise potassium channel regulation
Calcium burden: Pacemaker activity in these neurons creates high calcium flux, exacerbated by Kv dysfunction[@surmeier2017]
Mitochondrial stress: Calcium overload activates mitochondrial pathways leading to neuronal death

Amyotrophic Lateral Sclerosis

Motor neurons exhibit extreme excitability demands:

Hyperexcitability: Early feature in ALS, potentially linked to Kv subunit dysregulation
Excitotoxicity: Excessive calcium entry through NMDA receptors
Network destabilization: Progressive motor circuit dysfunction

Therapeutic Strategies

Pharmacological Modulation

Current potassium channel modulators include:

Kv5.1 presents challenges for direct pharmacological targeting due to its modulatory nature. However, selective targeting of Kv2.1/Kv5.1 complexes may be achievable.

Genetic Approaches

AAV-mediated expression modulation: Adjust Kv5.1 levels to normalize firing
CRISPR-based editing: Correct disease-associated variants
iPSC models: Patient-specific channels for drug screening

External Links

[NCBI Gene: KCNF1](https://www.ncbi.nlm.nih.gov/gene/3777)
[UniProt: KCNF1 (Kv5.1)](https://www.uniprot.org/uniprotkb/Q9H5Y4/entry)

Brain Atlas Resources

[Allen Human Brain Atlas - KCNF1](https://human.brain-map.org/microarray/search/show?search_term=KCNF1)
[Allen Cell Type Atlas](https://celltypes.brain-map.org/)
[BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/)
[Allen Mouse Brain Atlas](https://mouse.brain-map.org/)

References

[Bocksteins E, Snyders DJ, Electrophysiological and pharmacological properties of Kv channel alpha-subunits (2012)](https://pubmed.ncbi.nlm.nih.gov/22023642/)

[Gutman GA, Chandy KG, Grissmer S, et al, International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels (2003)](https://pubmed.ncbi.nlm.nih.gov/12761341/)

[Pongs O, Schwarz JR, Ancillary subunits associated with voltage-dependent K+ channels (2010)](https://pubmed.ncbi.nlm.nih.gov/11755194/)

[Styr B, Slutsky I, Imbalance between firing homeostasis and synaptic plasticity drives early-phase Alzheimer's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29185381/)

[Roselli F, Livrea P, Jirillo E, Voltage-gated potassium channels and neurodegenerative diseases (2009)](https://pubmed.ncbi.nlm.nih.gov/19635535/)

[Surmeier DJ, Halliday GM, Simuni T, Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease (2017)](https://pubmed.ncbi.nlm.nih.gov/24824502/)

📖 View canonical wiki page →

KCNF1 Gene

KCNF1 Gene

Overview

KCNF1 Gene

Overview

Gene And Protein Context

Mechanistic Role In Nervous-System Stress Biology

1. Repolarization And Firing Pattern Control

2. Calcium Burden Coupling

3. Circuit-Level Instability

Human Evidence Status

Translational Implications

Research Priorities

Kv Channel Family Context

Structural Features

Transmembrane Architecture

Heteromer Assembly

Disease-Specific Mechanisms

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Therapeutic Strategies

Pharmacological Modulation

Genetic Approaches

See Also

External Links

Brain Atlas Resources

References